ABOVE: © ISTOCK.COM,
ADAM SOOS
Update (June 18): The World Health Organization announced yesterday that it was dropping hydroxychloroquine from the Solidarity trial after new data suggest the drug is ineffective as a COVID-19 treatment or prophylaxis. A study published June 3 in the New England Journal of Medicine found that the drug did not prevent people exposed to SARS-CoV-2 from becoming sick, while findings released in a press statement from the UK RECOVERY trial on June 5 indicate that the drug does not improve survival or reduce hospital stay duration in COVID-19 patients.
Update (June 3): The World Health Organization today announced that it would be resuming hydroxychloroquine testing in its Solidarity Trial, following widespread criticism of The Lancet paper and the dataset it was based on.
The World Health Organization has suspended testing of the malaria drug hydroxychloroquine after a study published in The Lancet reported that COVID-19 ...
